USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online ...

Eli Lilly’s Phase I amylin data shows weight loss of 11.3% at 12 weeks, a “top-tier” result among the early datasets that have arrived for the new, hotly-anticipated weight loss modality, according to ...

Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Conducted by Weill Cornell Medicine, the study revealed that tirzepatide outperforms semaglutide in terms of weight loss and waist circumference reduction.

It contains tirzepatide, which is the active ingredient in the brand-name drug Mounjaro. If you cannot take Mounjaro for medical reasons, you may need compounded tirzepatide.

Discover how the tirzepatide weight loss study revealed boosted fat oxidation, appetite reduction, and key findings on metabolic adaptation resistance.

Erectile dysfunction affects over 40% of men over 40, yet our understanding of the condition remains limited. Research on this issue has mostly relied on real organs, making it difficult to study ...

What to know about reports that some men on weight loss drugs are experiencing erectile dysfunction (ED).

Researchers conducted a three-year-long study that involved about 500,000 men aged 40 and up and found health improvements in men who took drugs for erectile dysfunction.

The health study found medications commonly prescribed for erectile dysfunction are associated with significant reductions in deaths, cardiovascular disease, and dementia ...